NCT01925092View on ClinicalTrials.gov

Mifepristone in Children With Refractory Cushing's Disease

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

August 31, 2013

Primary Completion Date

December 31, 2016

Conditions
Cushing's Disease
Interventions
DRUG

mifepristone

tablets

Trial Locations (1)

20892-1103

National Institute of Child Health and Human Development (NICHD), Bethesda

Sponsors
All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

Corcept Therapeutics

INDUSTRY